Rafarma Pharmaceuticals, Inc. (RAFA)

Market Cap	5.99M -42.6%
Revenue (ttm)	133.33K
Net Income	-117.22K
EPS	-0.01
Shares Out	87.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Average Volume	44,711
Open	0.0750
Previous Close	0.0680
Day's Range	0.0500 - 0.0750
52-Week Range	0.0036 - 0.1779
Beta	0.63
RSI	55.91
Earnings Date	n/a

About Rafarma Pharmaceuticals

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: RAFA